Media Releases

The Armeo® Therapy Concept addresses the changing needs of the recovering patient from early rehabilitation through to home therapy By launching the ArmeoPower, the world’s first commercially available robotic arm exoskeleton, the Swiss medical technology company Hocoma completes its concept for neurorehabilitation of upper extremity. The Armeo Therapy Concept is the first concept that covers the whole “Continuum of Rehabilitation”, from early rehabilitation through to home therapy. Based on the same software platform, the Armeo Therapy Concept allows for a continuous documentation and tracking of the patient’s training progress. more

For Non-US media only. The Swiss-based medical technology company Hocoma presents the next generation of its early rehabilitation device Erigo® at the Medica in Düsseldorf from November 14 to 17, 2012. As the first system that combines robotic verticalization with functional electrical stimulation (FES), the device allows an even more effective early mobilization of neurological and bed-ridden patients. With its advanced new features, the Erigo is designed for a broader use in acute care. more

Robotic neurorehabilitation therapy device wins European Technology Transfer Award The successful collaboration between ETH Zurich and the Swiss medical technology company Hocoma was awarded with the 2012 Technology Transfer Award at the European Robotics Forum in Denmark last week. The world’s first commercially available robotic arm exoskeleton, the Armeo®Power, provides early rehabilitation for patients with severe neurological movement impairments. The most prestigious prize in European robotics is awarded annually for outstanding innovation and successful technology transfer among science and industry. more